I was one in eight. One in eight men will be diagnosed with prostate cancer in their lifetime. Nah, I was one in six. One in ...

PADDY POWER’S Even Bigger 180 campaign has smashed through the £1million mark. The Irish bookmaker renewed their pledge of £1 ...

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...

R&B star and local pastor Montell Jordan shared joyful news with fans, announcing that he is officially cancer free after a ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...

A new survey of UK radiologists finds that 100% of NHS trusts have now used pre-biopsy MRI, although variations persist in ...

Assessments used to calculate cardiovascular disease risk in the general population may not have the same predictive power ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

A new study reveals that only about 1 in 3 patients with prostate cancer have a successful first CT simulation, while 1 in 6 need to be rescheduled for another day.

Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in ...